Valence Life Sciences
9
29M
4
0.90
1
0.56
2
- Stages of investment
- Areas of investment
Summary
Valence Life Sciences is the famous VC, which was founded in 2012. The main department of described VC is located in the New York. The venture was found in North America in United States.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Valence Life Sciences, startups are often financed by Kleiner Perkins, InterWest Partners, Helix Ventures. The meaningful sponsors for the fund in investment in the same round are Kleiner Perkins, InterWest Partners, Wexford Capital. In the next rounds fund is usually obtained by Kleiner Perkins, InterWest Partners, HealthCare Royalty Partners.
The higher amount of exits for fund were in 2015. The real fund results show that this VC is 20 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2012. Opposing the other organizations, this Valence Life Sciences works on 11 percentage points more the average amount of lead investments. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The fund was created by Eric Roberts. We also calculated 2 valuable employees in our database.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Celator Pharmaceuticals, Invuity For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular fund investment industries, there are Pharmaceutical, Biotechnology.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 1
- Exits
- 2
- Rounds per year
- 0.90
- Follow on index
- 0.56
- Investments by industry
- Health Care (9)
- Medical Device (6)
- Biotechnology (5)
- Medical (3)
- Life Science (2) Show 4 more
- Investments by region
-
- United States (7)
- Germany (2)
- Peak activity year
- 2020
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Avg. valuation at time of investment
- 422M
- Group Appearance index
- 1.00
- Avg. company exit year
- 16
- Avg. multiplicator
- 6.99
- Strategy success index
- 0.67
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| CalciMedica | 22 May 2020 | Information Technology, Health Care, Life Science | Late Stage Venture | 15M | United States, California, San Diego |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.